The differential expression in GRNs identified in each patient also confirmed the tumor heterogeneity of SBA, with transcription factors (TFs) such as BATF, CREB3L1, KLF2, E2F1 variably expressed among different patients (Fig. 2e; Supplementary Fig. S4d). This evidence concerns the gene BATF and neoplasm.